JARISLOWSKY FRASER Ltd reduced its position in Nutrien Ltd. (NYSE:NTR - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 205,584 shares of the company's stock after selling 5,285 shares during the quarter. JARISLOWSKY FRASER Ltd's holdings in Nutrien were worth $9,194,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also modified their holdings of NTR. Norges Bank bought a new position in shares of Nutrien in the fourth quarter worth approximately $241,958,000. Arrowstreet Capital Limited Partnership boosted its position in shares of Nutrien by 159.5% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 5,435,627 shares of the company's stock worth $242,976,000 after purchasing an additional 3,341,169 shares during the period. ARGA Investment Management LP boosted its position in shares of Nutrien by 25.7% in the fourth quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company's stock worth $270,396,000 after purchasing an additional 1,236,671 shares during the period. Silchester International Investors LLP lifted its holdings in shares of Nutrien by 9.5% in the fourth quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company's stock worth $523,268,000 after buying an additional 1,009,895 shares in the last quarter. Finally, Barclays PLC lifted its holdings in shares of Nutrien by 192.7% in the fourth quarter. Barclays PLC now owns 411,056 shares of the company's stock worth $18,395,000 after buying an additional 854,543 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.
Nutrien Trading Down 2.0%
Shares of NTR traded down $1.17 during midday trading on Wednesday, hitting $56.89. The stock had a trading volume of 1,677,869 shares, compared to its average volume of 2,135,826. Nutrien Ltd. has a 1 year low of $43.70 and a 1 year high of $60.87. The firm has a market cap of $27.78 billion, a PE ratio of 41.53, a price-to-earnings-growth ratio of 1.19 and a beta of 0.79. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The stock's 50 day moving average is $52.35 and its 200 day moving average is $50.14.
Nutrien (NYSE:NTR - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.24). The firm had revenue of $4.67 billion during the quarter, compared to analysts' expectations of $5.16 billion. Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The company's revenue was down 5.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.46 EPS. As a group, analysts forecast that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.
Nutrien Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 18th. Stockholders of record on Monday, June 30th will be issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.83%. The ex-dividend date of this dividend is Monday, June 30th. Nutrien's payout ratio is presently 203.74%.
Analyst Upgrades and Downgrades
NTR has been the topic of several research analyst reports. UBS Group boosted their target price on shares of Nutrien from $52.00 to $56.00 and gave the stock a "neutral" rating in a report on Thursday, May 8th. Barclays boosted their target price on shares of Nutrien from $59.00 to $61.00 and gave the stock an "equal weight" rating in a report on Wednesday. Wells Fargo & Company boosted their target price on shares of Nutrien from $56.00 to $59.00 and gave the stock an "equal weight" rating in a report on Monday. TD Securities boosted their target price on shares of Nutrien from $64.00 to $67.00 and gave the stock a "buy" rating in a report on Monday. Finally, CIBC boosted their target price on shares of Nutrien from $64.00 to $66.00 and gave the stock an "outperformer" rating in a report on Tuesday, February 25th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $61.44.
View Our Latest Research Report on NTR
About Nutrien
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Further Reading

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.